NanoRay Biotech Co., Ltd. participated in Medical Fair Asia 2026, one of Southeast Asia’s leading medical trade exhibitions held in Singapore, showcasing to the international market its innovative achievements in medical imaging and precision radiotherapy, built upon the company’s unique core X-ray technology.
In medical diagnostics, NanoRay’s proprietary transmission X-ray technology provides high-contrast imaging with low radiation doses, helping to improve diagnostic accuracy, optimize clinical workflows, and enhance patient safety. During the exhibition, Chairman Su personally introduced NanoRay Biotech’s core technological advantages and product features, presenting the commercially available RevoluX Hand Radiographic Imaging System as well as the company’s newly developed handheld X-ray concept device. Both systems are designed with low radiation dose as a key feature. With its lightweight and convenient design, the handheld X-ray concept device aims to provide a safer and more flexible option for X-ray examinations.
In advanced therapeutics, NanoRay is actively advancing the clinical translation and commercialization of Advanced Molecular Therapy (AMT) as a combined precision radiotherapy approach, demonstrating the company’s strong R&D capabilities in precision radiation-based cancer treatment.
Through its participation in Medical Fair Asia 2026, NanoRay actively engaged with healthcare industry partners from around the world and sought international strategic partners and distributors to expand overseas collaboration opportunities and further advance the global application of its innovative X-ray technologies and precision healthcare solutions.